RB
APLT

Richmond Brothers’s Applied Therapeutics APLT Stock Holding History

Richmond Brothers’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-61,827
Closed -$289K – 35
2024
Q2 		$289K Hold
61,827
– – 0.57% 18
2024
Q1 		$420K Sell
61,827
-61,827
-50% -$278K 0.78% 16
2023
Q4 		$414K Hold
123,654
– – 0.72% 15
2023
Q3 		$308K Buy
+123,654
New +$204K 0.58% 16

Other funds holding APLT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Richmond Brothers's APLT Position: Q3 2024 in Review

Richmond Brothers sold out of Applied Therapeutics (APLT) in Q3 2024, closing a stake of 61,827 shares — an estimated $289K sold.

Richmond Brothers first reported a position in APLT in Q3 2023 and held it in 4 quarters. The position peaked at $420K in Q1 2024. 126 funds tracked by Wall St. Rank hold APLT as of Q3 2024.

  • Richmond Brothers reported no remaining Applied Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Richmond Brothers sold 61,827 Applied Therapeutics shares in Q3 2024, an estimated $289K.
  • Richmond Brothers first reported a position in Applied Therapeutics in Q3 2023 and held it in 4 quarters.
  • Richmond Brothers's Applied Therapeutics position peaked at $420K in Q1 2024.
  • 126 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2024.

Based on Richmond Brothers's 13F filing for Q3 2024, filed 12 Nov 2024.